Screener
Lucid Diagnostics LUCD Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -930.9%+169pp | -959.6%+185pp | -1,054.8%+4.8pp | -1,091.3%-13.9pp | -1,099.5%+73.2pp | |
| Net margin | -959.8%+308pp | -876.7%+605pp | -1,232.7%-185pp | -1,211.3%-141pp | -1,267.4%-39.6pp | |
| Returns | ||||||
| Return on equity | -556.3%-92.7pp | —— | -710.6%— | -331.2%+677pp | -463.6%-163pp | |
| Efficiency | ||||||
| Asset turnover | 0.1×0.0× | 0.2×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.3×+0.2× | 1.1×+0.3× | 1.3×+0.2× | 1.9×+0.7× | 1.1×-0.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×-0.2× | 0.4×— | 0.2×-0.3× | 0.1×-0.4× | 0.3×+0.1× | |
| Valuation | ||||||
| Market capitalization | $185.35M+44.4% | $195.92M+44.9% | $142.9M+194% | $102.91M+162% | $128.75M+249% | |
| Price / sales | 34×+4.6× | 38.2×+5.8× | 30.4×+19.2× | 23.4×+14.0× | 29.5×+19.8× | |
| Price / book | 17×+0.6× | 49×— | 13.1×+4.1× | 4×-2.2× | 16.4×+14.1× |
FAQ
- What are Lucid Diagnostics's profit margins?
- Lucid Diagnostics (LUCD) runs a -57.3% gross margin and a -930.9% operating margin, with a -959.8% net margin.
- Where do Lucid Diagnostics's ratios come from?
- Every ratio is computed from Lucid Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
